| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.8B | $8.0B | $6.6B | $5.9B | $4.7B | $1.1B | $1.3B | $1.2B |
| Cost of Revenue | $6.5B | $4.8B | $3.9B | $3.6B | $2.8B | $2.6B | $2.7B | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.7B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.0B | $1.0B | $0.4B | $0.2B | $0.4B | $1.0B | $1.3B | $0.8B |
| EPS (Basic) | $1.41 | $1.58 | $0.66 | $0.31 | $0.79 | $0.39 | $0.55 | $0.27 |
| EPS (Diluted) | $1.39 | $1.57 | $0.66 | $0.30 | $0.78 | $0.39 | $0.55 | $0.27 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $67.3B | $51.0B | $44.0B | $37.9B | $34.9B | $32.5B | $33.4B | $30.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $5.0B | $3.5B | $2.0B | $0.6B | $0.3B | $1.5B | $0.3B | $0.2B |
| Total Liabilities | $24.1B | $18.5B | $17.6B | $16.5B | $15.9B | $15.3B | $16.4B | $14.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $42.1B | $32.0B | $25.4B | $20.3B | $17.6B | $16.0B | $15.5B | $14.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.9B | $2.3B | $1.6B | $1.3B | $1.3B | $1.4B | $1.5B | $1.6B |
| Investing Cash Flow | $-10.5B | $-5.5B | $-5.7B | $-3.7B | $-4.5B | $2.3B | $-2.0B | $-2.4B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $9.0B | $4.9B | $5.4B | $2.8B | $1.6B | $-2.1B | $0.6B | $0.8B |